1. Regulation, reimbursement, and health technology assessment -- 2. Requirements and sources of data to complete an HTA -- 3. Meta-analysis -- 4. Network meta-analysis -- 5. Bayesian methods -- 6. Survival analysis -- 7. Costs and cost of illness studies -- 8. Health-related quality of life --...

<Emphasis Type="Bold">Background: The Common Drug Review (CDR) was created to provide a single process to review the comparative clinical efficacy and cost effectiveness of new drugs, and then to make formulary listing recommendations to Canadian publicly funded drug benefit plans. <Emphasis Type="Bold">Objective: The objective was to...</emphasis></emphasis>

The economic burden of influenza-related illness has been estimated to be $US71.3-166 billion in the US, the majority of which is attributable to indirect costs as a result of lost productivity. There are currently four antiviral drugs available for the treatment of influenza: two ion channel...

Background:Background: The Common Drug Review (CDR) was created to provide a single process to review the comparative clinical efficacy and cost effectiveness of new drugs, and then to make formulary listing recommendations to Canadian publicly funded drug benefit plans. Abstract:...

Evidence produced by multinational trial-based cost-effectiveness studies is often used to inform decisions concerning the adoption of new healthcare technologies. A key issue relating to the use of this type of evidence is the extent to which trial-wide economic results are applicable to every...